• Home >>
  • Materials and Chemicals

Global Gefitinib API Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2021-2027

  • ID : 1491515
  • Date : 29 Jan 2021
  • Region : Global
  • Pages :90

CHOOSE LICENCE TYPE

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Gefitinib API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Gefitinib API market segmented into Purity ? 98 % Purity ? 99 % Based on the end-use, the global Gefitinib API market classified into Gefitinib Tablets Others Based on geography, the global Gefitinib API market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Scion Pharm Taiwan Nischem International Jeil Pharmaceutical Farmhispania Group Brawn Laboratories Chem Genix Qilu Pharmaceutial Cipla Zhuhai Rundu Pharma Zhejiang Hisun Pharmaceutical

Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL GEFITINIB API INDUSTRY 2.1 Summary about Gefitinib API Industry 2.2 Gefitinib API Market Trends 2.2.1 Gefitinib API Production & Consumption Trends 2.2.2 Gefitinib API Demand Structure Trends 2.3 Gefitinib API Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Purity ? 98 % 4.2.2 Purity ? 99 % 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Gefitinib Tablets 4.3.2 Others 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Purity ? 98 % 5.2.2 Purity ? 99 % 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Gefitinib Tablets 5.3.2 Others 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Purity ? 98 % 6.2.2 Purity ? 99 % 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Gefitinib Tablets 6.3.2 Others 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Purity ? 98 % 7.2.2 Purity ? 99 % 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Gefitinib Tablets 7.3.2 Others 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Purity ? 98 % 8.2.2 Purity ? 99 % 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Gefitinib Tablets 8.3.2 Others 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Purity ? 98 % 9.2.2 Purity ? 99 % 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Gefitinib Tablets 9.3.2 Others 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Scion Pharm Taiwan 10.1.2 Nischem International 10.1.3 Jeil Pharmaceutical 10.1.4 Farmhispania Group 10.1.5 Brawn Laboratories 10.1.6 Chem Genix 10.1.7 Qilu Pharmaceutial 10.1.8 Cipla 10.1.9 Zhuhai Rundu Pharma 10.1.10 Zhejiang Hisun Pharmaceutical 10.2 Gefitinib API Sales Date of Major Players (2017-2020e) 10.2.1 Scion Pharm Taiwan 10.2.2 Nischem International 10.2.3 Jeil Pharmaceutical 10.2.4 Farmhispania Group 10.2.5 Brawn Laboratories 10.2.6 Chem Genix 10.2.7 Qilu Pharmaceutial 10.2.8 Cipla 10.2.9 Zhuhai Rundu Pharma 10.2.10 Zhejiang Hisun Pharmaceutical 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

1.Table Gefitinib API Product Type Overview 2.Table Gefitinib API Product Type Market Share List 3.Table Gefitinib API Product Type of Major Players 4.Table Brief Introduction of Scion Pharm Taiwan 5.Table Brief Introduction of Nischem International 6.Table Brief Introduction of Jeil Pharmaceutical 7.Table Brief Introduction of Farmhispania Group 8.Table Brief Introduction of Brawn Laboratories 9.Table Brief Introduction of Chem Genix 10.Table Brief Introduction of Qilu Pharmaceutial 11.Table Brief Introduction of Cipla 12.Table Brief Introduction of Zhuhai Rundu Pharma 13.Table Brief Introduction of Zhejiang Hisun Pharmaceutical 14.Table Products & Services of Scion Pharm Taiwan 15.Table Products & Services of Nischem International 16.Table Products & Services of Jeil Pharmaceutical 17.Table Products & Services of Farmhispania Group 18.Table Products & Services of Brawn Laboratories 19.Table Products & Services of Chem Genix 20.Table Products & Services of Qilu Pharmaceutial 21.Table Products & Services of Cipla 22.Table Products & Services of Zhuhai Rundu Pharma 23.Table Products & Services of Zhejiang Hisun Pharmaceutical 24.Table Market Distribution of Major Players 25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 27.Table Global Gefitinib API Market Forecast (Million USD) by Region 2021f-2026f 28.Table Global Gefitinib API Market Forecast (Million USD) Share by Region 2021f-2026f 29.Table Global Gefitinib API Market Forecast (Million USD) by Demand 2021f-2026f 30.Table Global Gefitinib API Market Forecast (Million USD) Share by Demand 2021f-2026f 1.Figure Global Gefitinib API Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Gefitinib API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Gefitinib API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Gefitinib API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Gefitinib API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Gefitinib API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Gefitinib API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure Gefitinib Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Gefitinib API Sales Revenue (Million USD) of Scion Pharm Taiwan 2017-2020e 60.Figure Gefitinib API Sales Revenue (Million USD) of Nischem International 2017-2020e 61.Figure Gefitinib API Sales Revenue (Million USD) of Jeil Pharmaceutical 2017-2020e 62.Figure Gefitinib API Sales Revenue (Million USD) of Farmhispania Group 2017-2020e 63.Figure Gefitinib API Sales Revenue (Million USD) of Brawn Laboratories 2017-2020e 64.Figure Gefitinib API Sales Revenue (Million USD) of Chem Genix 2017-2020e 65.Figure Gefitinib API Sales Revenue (Million USD) of Qilu Pharmaceutial 2017-2020e 66.Figure Gefitinib API Sales Revenue (Million USD) of Cipla 2017-2020e 67.Figure Gefitinib API Sales Revenue (Million USD) of Zhuhai Rundu Pharma 2017-2020e 68.Figure Gefitinib API Sales Revenue (Million USD) of Zhejiang Hisun Pharmaceutical 2017-2020e 69.

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology